Network pharmacology-based strategy for predicting active ingredients and potential targets of Yangxinshi tablet for treating heart failure

被引:71
|
作者
Chen, Langdong [1 ]
Cao, Yan [1 ]
Zhang, Hai [2 ]
Lv, Diya [1 ]
Zhao, Yahong [3 ]
Liu, Yanjun [3 ]
Ye, Guan [3 ]
Chai, Yifeng [1 ]
机构
[1] Second Mil Med Univ, Sch Pharm, Shanghai 200433, Peoples R China
[2] Tongji Univ, Shanghai Matern & Infant Hosp 1, Sch Med, Dept Pharm, Shanghai 201204, Peoples R China
[3] Shanghai Pharmaceut Holding Co Ltd, Cent Res Inst, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
Yangxinshi tablet; Network pharmacology; Heart failure; CONVERTING ENZYME-INHIBITORS; NF-KAPPA-B; PPAR-GAMMA; PROTEIN; DIFFERENTIATION; MECHANISM; APOPTOSIS; FORMULA; AGENTS; MAPK;
D O I
10.1016/j.jep.2017.12.011
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Yangxinshi tablet (YXST) is an effective treatment for heart failure and myocardial infarction; it consists of 13 herbal medicines formulated according to traditional Chinese Medicine (TCM) practices. It has been used for the treatment of cardiovascular disease for many years in China. Materials and methods: In this study, a network pharmacology-based strategy was used to elucidate the mechanism of action of YXST for the treatment of heart failure. Cardiovascular disease-related protein target and compound databases were constructed for YXST. A molecular docking platform was used to predict the protein targets of YXST. The affinity between proteins and ingredients was determined using surface plasmon resonance (SPR) assays. The action modes between targets and representative ingredients were calculated using Glide docking, and the related pathways were predicted using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. Results: A protein target database containing 924 proteins was constructed; 179 compounds in YXST were identified, and 48 compounds with high relevance to the proteins were defined as representative ingredients. Thirty-four protein targets of the 48 representative ingredients were analyzed and classified into two categories: immune and cardiovascular systems. The SPR assay and molecular docking partly validated the interplay between protein targets and representative ingredients. Moreover, 28 pathways related to heart failure were identified, which provided directions for further research on YXST. Conclusions: This study demonstrated that the cardiovascular protective effect of YXST mainly involved the immune and cardiovascular systems. Through the research strategy based on network pharmacology, we analysis the complex system of YXST and found 48 representative compounds, 34 proteins and 28 related pathways of YXST, which could help us understand the underlying mechanism of YSXT's anti-heart failure effect. The network-based investigation could help researchers simplify the complex system of YXSY. It may also offer a feasible approach to decipher the chemical and pharmacological bases of other TCM formulas.
引用
收藏
页码:359 / 368
页数:10
相关论文
共 50 条
  • [21] Network Pharmacology-Based Approach to Comparatively Predict the Active Ingredients and Molecular Targets of Compound Xueshuantong Capsule and Hexuemingmu Tablet in the Treatment of Proliferative Diabetic Retinopathy
    Yao, Hongyan
    Xin, Danli
    Zhan, Zongyi
    Li, Zijing
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [22] Network pharmacology-based and clinically relevant prediction of active ingredients and potential targets of Chinese herbs on stage IV lung adenocarcinoma patients
    Liu, Jinfeng
    Hao, Jian
    Niu, Yangyang
    Wu, Xiongzhi
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (07) : 2079 - 2092
  • [23] Network pharmacology-based and clinically relevant prediction of active ingredients and potential targets of Chinese herbs on stage IV lung adenocarcinoma patients
    Jinfeng Liu
    Jian Hao
    Yangyang Niu
    Xiongzhi Wu
    [J]. Journal of Cancer Research and Clinical Oncology, 2021, 147 : 2079 - 2092
  • [24] Revealing active ingredients, potential targets, and action mechanism of Ermiao fang for treating endometritis based on network pharmacology strategy (vol 260, 113051, 2020)
    Zhang, Chao
    Su, Tong
    Yu, Dan
    Wang, Fei
    Yue, Chunhua
    Wang, Hai-Qiao
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2021, 265
  • [25] A network pharmacology based approach for predicting active ingredients and potential mechanism of Lianhuaqingwen capsule in treating COVID-19
    Zhang, Xiaobo
    Gao, Rui
    Zhou, Zubing
    Tang, Xuehua
    Lin, Jingjing
    Wang, Long
    Zhou, Xin
    Shen, Tao
    [J]. INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2021, 18 (08): : 1866 - 1876
  • [26] Network pharmacology-based prediction of the active ingredients, potential targets, and signaling pathways in compound Lian-Ge granules for treatment of diabetes
    Xue, Jintao
    Shi, Yongli
    Li, Chunyan
    Song, Huijie
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (04) : 6431 - 6440
  • [27] Network pharmacology-based screening of the active ingredients and mechanisms of Huangqi against aging
    Lan, Siyu
    Duan, Jie
    Zeng, Nan
    Yu, Bin
    Yang, Xuping
    Ning, Hong
    Huang, Yilan
    Rao, Youyi
    [J]. MEDICINE, 2021, 100 (17) : E25660
  • [28] Network Pharmacology-Based Approach to Investigate the Molecular Targets of Rhubarb for Treating Cancer
    Jiang, Lan
    Shi, Zhongquan
    Yang, Yi
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [29] Network pharmacology-based prediction of the active ingredients and mechanism of Shen Gui capsule for application to coronary heart disease
    Wang, Dan
    Tian, Li
    Shi, Chang
    Wei, Yu-Xi
    Wang, Han
    Liu, Tian-Tian
    Gong, Ming
    Zhang, Yan-Wen
    Yu, Rong-Guo
    Wu, Xiao-Hui
    [J]. COMPUTERS IN BIOLOGY AND MEDICINE, 2020, 122
  • [30] Network Pharmacology-Based Strategy and Molecular Docking to Explore the Potential Mechanism of Jintiange Capsule for Treating Osteoporosis
    Yang, Zhao
    Yuan, Zhen-Zhen
    Ma, Xin-Long
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021